Single photon emission tomography (SPET) with 99Tc m-hexamethylpropyleneamineoxime (HMPAO) in research and clinical practice - a useful tool

Hounsfield GN Computerised transverse axial scanning (tomography): Part 1. Description of system. Br J Radiol 1973; 46: 1016-22.

Baker Jr HL , Campbell JK , Houser OW , Reese DF , Sheedy PF , Holman CB Computer assisted tomography of the head. An early evaluation. Mayo Clin Proc 1974; 49: 17-27.

Jacoby R. , Levy R. Computed tomography in the elderly: 2. senile dementia: diagnosis and functional impairment. Br J Psychiatry 1980; 136: 256-69.

Colgan J. , Naguib M. , Levy R. Computed tomographic density numbers. A comparative study of patients with senile dementia and normal elderly controls. Br J Psychiatry 1986; 149: 716-19.

Pinching AJ Neurological aspects of the acquired immune deficiency syndrome. J R Coll Phys Lond 1988; 22: 136-39.

Ell PJ , Costa DC , Harrison Mgj. Imaging cerebral damage in HIV infection. Lancet 1987; ii: 569-70.

Hinshaw WS , Bottomley PA , Holland GN Radiographic thin-section image of the human wrist by nuclear magnetic resonance . Nature 1977; 279: 722-23.

Mansfield P. , Maudsley AA Medical imaging by NMR. Br J Radiol 1977; 50: 188-94.

Nakada T. , Kwee IL , Griffey BV , Griffey RH F-19 MR imaging of glucose metabolism in the rabbit. Radiology 1988; 168: 823-25.

Sokoloff L. , Reivich M. , Kennedy C. et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilisation: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897-916.

Ingvar DH , Lassen NA Quantitative determination of regional cerebral blood flow in man. Lancet 1961; ii: 806-807.

Veall N. , Mallett BL The two-compartment model using 133Xe inhalation and external counting. Acta Neurol Scand 1965; 14 (suppl): 83-84.

Reivich M. , Kuhl D. , Wolf A. et al. The [18F]fluoro-deoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979; 44: 127-37.

Kety SS , Schmidt CF The determination of cerebral blood flow in man by the use of nitrous oxide in low concentrations. Am J Physiol 1945; 143: 53-66.

Kety SS , Schmidt CF The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest 1948; 27: 476-83.

Kety SS , Woodford RB , Harmel MH , Freyhan FA , Appel KE , Schmidt CF Cerebral blood flow and metabolism in schizophrenia. The effects of barbiturate semi-narcosis, insulin coma and electroshock. Am J Psychiatry 1948; 104: 765-70.

Kety SS The measurement of regional circulation by local clearance of radioactive sodium. Am Heart J 1949; 38: 321-28.

Lassen NA , Lindbjerg IF , Munck O. Measurement of blood flow through skeletal muscle by intramuscular injection of 133Xe. Lancet 1964; i: 686-89.

Hoedt-Rasmussen L. , Sveinsdottir E. , Lassen NA Regional cerebral blood flow in man determined by intra-arterial injection of radioactive inert gas. Circ Res 1966; 18: 237-47.

Obrist WD , Thompson HK , King CH , Wang HS Determination of regional cerebral blood flow by inhalation of 133-xenon. Circ Res 1967; 20: 124-35.

Rosenstein J. , Suzuki M. , Symon L. , Redmond S. Clinical use of a portable bedside cerebral blood flow machine in the management of aneurysmal subarachnoid hemorrhage . Neurosurgery 1984; 15: 519-25.

Agnoli A. , Prencipe M. , Priori Aam , Bozzao I. , Fieschi C. Measurements of rCBF by intravenous injection of 133-xenon. In: Brock M , Fieschi C , Ingvar DH , Lassen NA , Schurmann K eds, Cerebral blood flow, Berlin, Heidelberg, New York : Springer Verlag, 1969: 31-34.

Obrist WD , Wang HS Comparison of 133-xenon inhalation and IV injection in regional CBF studies . In: Meyer JS , Lechner H , Reivich M , Ott EO , Arabinar A eds, Cerebral vascular disease, Amsterdam: Excerpta Medica, 1981: 140-44.

Naritomi H. , Meyer JS , Sakai F. , Yamaguchi F. , Shaw T. Effects of advancing age on regional cerebral blood flow. Arch Neurol 1979; 36: 410-16.

Melamed E. , Lavy S. , Bentin S. , Cooper G. , Rinot Y. Reduction in regional cerebral blood flow during normal aging in man. Stroke 1980; 11: 31-35.

Yanagihara T. , Wahner HW Cerebral blood flow measurement in cerebrovascular occlusive diseases. Stroke 1984; 15: 816-22.

Muizelaar JP , Lutz HA , Becker DP Effect of manitol on ICP and CBF and correlation with pressure auto-regulation in severely head-injured patients. J Neurosurg 1984; 61: 700-706.

Lavy S. , Melamed E. , Bentin S. , Cooper G. , Rinot Y. Bihemispheric decreases of regional cerebral blood flow in dementia: correlation with age-matched normal controls. Ann Neurol 1978; 4: 445-50.

Gur RE , Skolnick BE , Gur RC et al. Brain function in psychiatric disorders: II regional cerebral blood flow in medicated unipolar depressives. Arch Gen Psychiatry 1984; 41: 695-99.

Kanno I. , Lassen NA Two methods for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr 1979; 3: 71-76.

Lassen NA , Sveinsdottir E. , Kanno I. , Stokely EM , Rommer P. A fast moving, single photon emission tomograph for regional cerebral blood flow studies in man. J Comput Assist Tomogr 1978; 2: 661-62.

Kety SS The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3: 1-41.

Celsis P. , Goldman T. , Henriksen L. , Lassen NA A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr 1981; 5: 641-45.

Winchell HS , Baldwin RM , Lin TH Development of I-123 labelled amines for brain studies: localization of I-123 iodophenylalkylamines in rat brain. J Nucl Med 1980; 21: 940-46.

Winchell HS , Horst WD , Braun L. , Oldendorf WH , Hattner R. , Parker H. N-isopropyl [123I]-p-iodoamphetamine: single-pass brain uptake and washout; binding to brain synaptosomes; and localization in dog and monkey brain. J Nucl Med 1980; 21: 947-52.

Kung HF , Blau M. Regional intracellular pH shift: a proposed new mechanism for radiopharmaceutical uptake in brain and other tissues. J Nucl Med 1980; 21: 147-52.

Kung FH , Tramposch KM , Blau M. A new brain perfusion imaging agent: [I-123]HIPDM:N,N,N'-trimethyl-N'-[2-hydroxy-3-methyl-5-iodobenzyl]-1,3-propanediamine . J Nucl Med 1984; 24: 66-72.

Holman BL , Hill TC , Lee Rgl , Zimmerman RE , Moore SC , Royal HD Brain imaging with radiolabelled amines. Nuclear Medicine Annual 1983: 131-65.

Royal HD , Hill TC , Holman BL Clinical brain imaging with isopropyliodoamphetamine and SPECT. Semin Nucl Med 1985; 15: 357-76.

Loberg MD Radiotracers for cerebral functional imaging - a new class. J Nucl Med 1980; 21: 183-85.

Berl S. , Takagaki G. , Clarke DD , Waelsch H. Metabolic compartments in vivo. Ammonia and glutamic acid metabolism in brain and liver. J Biol Chem 1962; 237: 2562-69.

Ibister WH , Schofield PF , Torrance HB Measurement of the solubility of xenon-133 in blood and human brain. Phys Med Biol 1965; 10: 243-50.

Oldendorf WH Need for new radiopharmaceuticals. J Nucl Med 1978; 19: 1182.

Kung HF , Molnar M. , Billings J. , Wicks R. , Blau M. Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier. J Nucl Med 1984; 25: 326-32.

Volkert WA , McKenzie EH , Hoffman TJ , Troutner DE , Holmes RA The behaviour of neutral amine oxime chelates labelled with Tc at tracer level . Int J Nucl Med Biol 1984; 11: 243-46.

Troutner DE , Volkert WA , Hoffman TJ , Holmes RA A neutral lipophilic complex of Tc-99m with a multidentate amine oxime. Int J Appl Radiat Isot 1984; 35: 467-70.

Volkert WA , Hoffman TJ , Seger RM , Troutner DE , Holmes RA 99mTc-propylene amine oxime (99mTc-PnAO): a potential brain radiopharmaceutical . Eur J Nucl Med 1984; 9: 511-16.

Holmes RA , Chaplin SB , Royston KG et al. Cerebral uptake and retention of 99Tcmhexamethylpropyleneamine oxime (99Tcm-HM-PAO). Nucl Med Commun 1985 ; 6: 443-47.

Ell PJ , Cullum I. , Costa DC et al. A new regional cerebral blood flow mapping with 99mTc-labelled compound. Lancet 1985; ii: 50-51.

Ell PJ , Hocknell Jml , Jarritt PH et al. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease. Nucl Med Commun 1985; 6: 437-41.

Costa DC , Ell PJ , Nowotnik DP HM-PAO: a new technitium-99m labelled agent for brain SPECT. J Nucl Med Allied Sciences 1985; 29: 337- 38.

Nowotnik DP , Canning LR , Cumming SA et al. Tc-99m-HM-PAO: a new radiopharmaceutical for imaging regional cerebral blood flow. In: Nicolini, Bandoli MG , Mazzi U eds, Technetium in Chemistry and Nuclear Medicine 2, New York: Raven Press, 1986: 187-92.

Pickett RD The biodistribution of technetium 99m-HMPAO in rats. Amersham International, 1985.

Pickett RD Calculation of radiation doses to subjects following intravenous injection of Tc-99m-HM-PAO. Amersham International, 1985.

Costa DC , Jones BE , Steiner TJ et al. Relative 99mTc-HM-PAO and 113Sn-microspheres distribution in dog brain. Nuklearmedizin 1987; (suppl 23): 498-500.

Altman DG , Bland JM Measurement in medicine: the analysis of method comparison studies. The Statistician 1983; 32: 307-17.

Costa DC , Lui D. , Sinha AK , Jarritt PH , Ell PJ Intracellular localisation of 99Tcm-d,l-HMPAO and 201Tl-DDC in rat brain. Nucl Med Commun 1989.

Costa DC , Hubank M. , Sinha A. , Lui D. , Ell PJ Influence of time, temperature, sodium-potassium pump inhibition and glutathione on the 99Tcm-HMPAO uptake by cultured astrocytes. Eur J Nucl Med 1989; 15: 584.

Costa DC , Lui D. , Ell PJ Tc-99m-HMPAO uptake in rat brain: sensitivity to physiological and pharmacological intervention 'in vivo'. Nucl Med 1987; 26: 146-47.

Choksey MS , Costa DC , Iannotti I. , Ell PJ , Crockard HA 99mTc-HMPAO SPET and cerebral blood flow, a study of CO2 reactivity . Nucl Med Commun 1989; 10: 609-18.

Costa DC , Davies Ptg , Jones BE , Steiner TJ , Jewkes RF , Clifford Rose F. 99Tcm-HMPAO studies in patients with migraine, tension and cluster headache . Nucl Med Commun 1988; 9: 196-97.

Costa DC , Stibe Cma , Lees AJ et al. Tc-99m-HMPAO rCBF/SPET in Parkinsonians with the 'ON-OFF' syndrome: preliminary results. Nuklearmedizin 1988; (suppl 24): 344-47.

Costa DC , Ell PJ Focal temporal lobe epilepsy: oblique reconstruction and slice re-orientation improves HMPAO/SPET analysis. Nucl Med Commun 1989; 10: 231.

Costa DC , Ell PJ , Burns A. , Philpot M. , Levy R. CBF tomograms with [99mTc]-HM-PAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - initial results. J Cereb Blood Flow Metab 1988; 8: S109-15.

Burns A. , Philpot M. , Costa DC , Ell PJ , Levy R. The investigation of Alzheimer's disease with single photon emission tomography . J Neurol Neurosurg Psychiatry 1989; 52: 248-53.

Costa DC , Philpot M. , Burns A. , Ell PJ , Levy R. Clinical presentation vs. quantitative HMPAO/SPET in the follow-up of patients with dementia of Alzheimer type (DAT). Nucl Med 1990; (suppl 26): 352-54.

Costa DC , Ell PJ 99mTc-HMPAO washout in prognosis of stroke. Lancet 1989; i: 213-14.

Costa DC A study of the first 99Tcm-labelled radiopharmaceutical for the investigation of cerebral flow in man (Thesis). London: University of London, 1989.

Ell PJ , Hocknell Jml , Costa DC et al. 99mTChexamethyl-propyleneamineoxime (99mTc-HM-PAO): a breakthrough in radionuclide CBF tomography. Nuklearmedizin 1986; (suppl 22): 179-81.

Costa DC , Ell PJ , Cullum ID , Jarritt PH The in vivo distribution of 99Tcm-HM-PAO in normal man. Nucl Med Commun 1986; 7: 647-58.

Sharp PF , Smith FW , Gemmell HG et al. Technetium- 99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med 1986; 27: 171-77.

El-Gazzar AH , Sadek S. , Bahar R. , Rageb A. , Omar YT , Abdel-Dayem HM Uptake of Tc-99m-hexamethylpropyleneamineoxime (Tc-99m-HM-PAO) by healthy and diseased lungs. Nucl Med 1987; 26: 149-90.